Citius Pharmaceuticals, Inc. Increase (Decrease) in Accrued Salaries
Citius Pharmaceuticals, Inc. (CTXR) reported Increase (Decrease) in Accrued Salaries of -$143.75 thousand for the 12-month period ending 2022-09-30, per its 10-K filed 2022-12-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedSalaries · last filed 2022-12-22
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued salaries for the quarter ending 2022-09-30 was $484.75K, a 32.38% increase year-over-year.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued salaries for the quarter ending 2022-06-30 was $484.25K, a 31.79% increase year-over-year.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued salaries for the quarter ending 2022-03-31 was -$1.44M.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued salaries for the quarter ending 2021-12-31 was $327.69K, a 45.08% increase year-over-year.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued salaries for fiscal 2022 was -$143.75K, a 157.25% decline from fiscal 2021.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued salaries for fiscal 2021 was $251.08K, a 1.24% decline from fiscal 2020.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued salaries for fiscal 2020 was $254.23K, a 26.00% increase from fiscal 2019.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued salaries for fiscal 2019 was $201.77K, a 48.46% increase from fiscal 2018.
| Period end | Increase (Decrease) in Accrued Salaries 3 month | Increase (Decrease) in Accrued Salaries 6 month | Increase (Decrease) in Accrued Salaries 9 month | Increase (Decrease) in Accrued Salaries 12 month |
|---|---|---|---|---|
| 2022-09-30 | $484.75K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $969.00K derived: sum of 2 quarters · filed 2022-12-22 | -$471.44K derived: sum of 3 quarters · filed 2022-12-22 | -$143.75K 10-K · filed 2022-12-22 |
| 2022-06-30 | $484.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | -$956.19K derived: sum of 2 quarters · filed 2022-08-11 | -$628.50K 10-Q · filed 2022-08-11 | -$262.31K derived: sum of 4 quarters · filed 2022-12-22 |
| 2022-03-31 | -$1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | -$1.11M 10-Q · filed 2022-05-12 | -$746.56K derived: sum of 3 quarters · filed 2022-12-22 | -$379.13K derived: sum of 4 quarters · filed 2022-12-22 |
| 2021-12-31 | $327.69K 10-Q · filed 2022-02-10 | $693.88K derived: sum of 2 quarters · filed 2022-12-22 | $1.06M derived: sum of 3 quarters · filed 2022-12-22 | $352.90K derived: sum of 4 quarters · filed 2022-12-22 |
| 2021-09-30 | $366.19K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $733.63K derived: sum of 2 quarters · filed 2022-12-22 | $25.21K derived: sum of 3 quarters · filed 2022-12-22 | $251.08K 10-K · filed 2022-12-22 |
| 2021-06-30 | $367.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | -$340.98K derived: sum of 2 quarters · filed 2022-08-11 | -$115.11K 10-Q · filed 2022-08-11 | $319.50K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$708.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | -$482.54K 10-Q · filed 2022-05-12 | -$47.94K derived: sum of 3 quarters · filed 2022-05-12 | $140.50K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $225.88K 10-Q · filed 2022-02-10 | $660.48K derived: sum of 2 quarters · filed 2022-02-10 | $848.92K derived: sum of 3 quarters · filed 2022-02-10 | $404.81K derived: sum of 4 quarters · filed 2022-02-10 |
| 2020-09-30 | $434.61K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15 | $623.04K derived: sum of 2 quarters · filed 2021-12-15 | $178.94K derived: sum of 3 quarters · filed 2021-12-15 | $254.23K 10-K · filed 2021-12-15 |
| 2020-06-30 | $188.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | -$255.67K derived: sum of 2 quarters · filed 2021-08-12 | -$180.37K 10-Q · filed 2021-08-12 | $14.63K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$444.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-13 | -$368.81K 10-Q · filed 2021-05-13 | -$173.81K derived: sum of 3 quarters · filed 2021-05-13 | $11.88K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $75.30K 10-Q · filed 2021-02-11 | $270.30K derived: sum of 2 quarters · filed 2021-02-11 | $455.98K derived: sum of 3 quarters · filed 2021-02-11 | $94.57K derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-09-30 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-16 | $380.69K derived: sum of 2 quarters · filed 2020-12-16 | $19.27K derived: sum of 3 quarters · filed 2020-12-16 | $201.77K 10-K · filed 2020-12-16 |
| 2019-06-30 | $185.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-14 | -$175.73K derived: sum of 2 quarters · filed 2020-08-14 | $6.77K 10-Q · filed 2020-08-14 | $269.94K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | -$361.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-14 | -$178.91K 10-Q · filed 2020-05-14 | $84.25K derived: sum of 3 quarters · filed 2020-05-14 | $224.63K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $182.50K 10-Q · filed 2020-02-13 | $445.66K derived: sum of 2 quarters · filed 2020-02-13 | $586.04K derived: sum of 3 quarters · filed 2020-02-13 | $178.04K derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-09-30 | $263.16K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $403.54K derived: sum of 2 quarters · filed 2019-12-16 | -$4.46K derived: sum of 3 quarters · filed 2019-12-16 | $135.91K 10-K · filed 2019-12-16 |
| 2018-06-30 | $140.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | -$267.63K derived: sum of 2 quarters · filed 2019-08-14 | -$127.25K 10-Q · filed 2019-08-14 | -$282.61K derived: sum of 4 quarters · filed 2019-12-16 |
| 2018-03-31 | -$408.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | -$267.63K 10-Q · filed 2019-05-15 | -$422.99K derived: sum of 3 quarters · filed 2019-12-16 | -$286.99K derived: sum of 4 quarters · filed 2019-12-16 |
| 2017-12-31 | $140.38K 10-Q · filed 2019-02-14 | -$14.99K derived: sum of 2 quarters · filed 2019-12-16 | $121.01K derived: sum of 3 quarters · filed 2019-12-16 | $192.88K derived: sum of 4 quarters · filed 2019-12-16 |
| 2017-09-30 | -$155.37K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | -$19.36K derived: sum of 2 quarters · filed 2019-12-16 | $52.50K derived: sum of 3 quarters · filed 2019-12-16 | $159.75K 10-K · filed 2019-12-16 |
| 2017-06-30 | $136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | $207.87K derived: sum of 2 quarters · filed 2018-08-14 | $315.12K 10-Q · filed 2018-08-14 | |
| 2017-03-31 | $71.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | $179.12K 10-Q · filed 2018-05-11 | ||
| 2016-12-31 | $107.25K 10-Q · filed 2018-02-14 | |||
| 2016-09-30 | $288.25K 10-K · filed 2018-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |